HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong-Yu Wang Selected Research

Breast Neoplasms (Breast Cancer)

8/2017microRNA-143/145 loss induces Ras signaling to promote aggressive Pten-deficient basal-like breast cancer.
12/2014Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K.
5/2012Lunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.
9/2011A new gene expression signature, the ClinicoMolecular Triad Classification, may improve prediction and prognostication of breast cancer at the time of diagnosis.
6/2011Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
7/2010Troglitazone suppresses telomerase activity independently of PPARgamma in estrogen-receptor negative breast cancer cells.
9/2008The effects of timing of fine needle aspiration biopsies on gene expression profiles in breast cancers.
12/2004Gene expression profiles for detecting and distinguishing potential endocrine-disrupting compounds in environmental samples.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong-Yu Wang Research Topics

Disease

13Neoplasms (Cancer)
05/2023 - 07/2010
8Breast Neoplasms (Breast Cancer)
08/2017 - 12/2004
4Triple Negative Breast Neoplasms
05/2023 - 01/2018
1Retinoblastoma (Glioblastoma, Retinal)
05/2023
1Pinealoma (Pineoblastoma)
01/2020
1Neoplasm Metastasis (Metastasis)
01/2019
1Chromosome Aberrations (Chromosome Abnormalities)
08/2017
1Hepatocellular Carcinoma (Hepatoma)
12/2016
1Osteosarcoma (Osteogenic Sarcoma)
05/2016
1Carcinogenesis
02/2016
1Myoma
09/2010

Drug/Important Bio-Agent (IBA)

4Phenobarbital (Luminal)FDA Link
12/2019 - 05/2012
3MicroRNAs (MicroRNA)IBA
12/2019 - 08/2017
3Estrogen ReceptorsIBA
09/2011 - 12/2004
2Doxorubicin (Adriamycin)FDA LinkGeneric
05/2016 - 12/2014
2ClaudinsIBA
12/2014 - 05/2012
2DNA (Deoxyribonucleic Acid)IBA
06/2011 - 09/2008
1poliovirus receptorIBA
05/2023
1Immunologic Factors (Immunomodulators)IBA
05/2023
1Transcription Factors (Transcription Factor)IBA
05/2023
1B7-H1 AntigenIBA
05/2023
1GemcitabineFDA Link
01/2020
1Cathepsin BIBA
01/2020
1Nortriptyline (Aventyl)FDA LinkGeneric
01/2020
1Antineoplastic Agents (Antineoplastics)IBA
01/2020
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
01/2020
1Androgen Receptors (Androgen Receptor)IBA
12/2019
1human MIRN381 microRNAIBA
01/2019
1cdc25 PhosphatasesIBA
01/2018
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
08/2017
1Kruppel-Like Factor 6IBA
12/2016
1Proteins (Proteins, Gene)FDA Link
05/2016
1Phosphotransferases (Kinase)IBA
05/2016
1Methotrexate (Mexate)FDA LinkGeneric
05/2016
1CaveolinsIBA
05/2012
1RNA (Ribonucleic Acid)IBA
06/2011
1Formaldehyde (Formol)FDA Link
06/2011
1ParaffinIBA
06/2011
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
09/2010
1Hormones (Hormone)IBA
09/2010
1PPAR gammaIBA
07/2010
1Messenger RNA (mRNA)IBA
07/2010
1Telomerase (Telomerase Reverse Transcriptase)IBA
07/2010
1LigandsIBA
07/2010
1Troglitazone (Rezulin)FDA Link
07/2010
1Estrogens (Estrogen)FDA Link
12/2004

Therapy/Procedure

4Therapeutics
05/2023 - 02/2016